Study registry for morphea and storing DNA samples
Part of Skin clinical trials.
This study is building a registry (a group record) of people with morphea and collecting DNA samples to help researchers learn more about the condition. It may help by improving understanding of causes, patterns, and future treatments.
Summary written for real people, not researchers, by Clin2.
Who can take part
- A doctor must confirm your morphea diagnosis, including looking at a biopsy under a microscope
- You must be between ages 0 and 90
- If you are a child, you must weigh more than 20 pounds for blood-draw limits
- You (or your parent/guardian) must be able to speak and read at about a 6th-grade level
- You must be able to agree to participate (or, if a minor, your parent/guardian agrees and you assent)
- Your diagnosis must be morphea or localized scleroderma—not another similar condition
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study builds a registry of people with scleroderma and may store medical information and samples for future research. It can help researchers better understand the disease and develop better treatments.
This study uses a special ultrasound (elastography) to measure how stiff or thick your skin patches are over time. It helps doctors understand morphea better and see if treatment is working, with no extra needles or radiation.
This trial collects skin samples from people with scleroderma and from healthy volunteers undergoing plastic surgery. Researchers will study the genes in skin cells to better understand the disease.
This study follows adults with systemic scleroderma (also called scleroderma) to better understand the condition over time. You may be included if you meet specific diagnosis and blood-test requirements and can give informed consent.
This study follows adults with systemic sclerosis who are being seen at a specific hospital and asks for consent to store blood and other samples for future research. It may help researchers better understand the disease and develop better tests or treatments over time.
This study looks at families where two first-degree relatives have systemic scleroderma, a rare autoimmune disease that affects the skin and organs. It aims to understand genetic and environmental factors by examining patients and their family members.
Hear when a new Scleroderma, Localized trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.